These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

648 related items for PubMed ID: 17923426

  • 21. Peripheral arterial disease: a review of disease awareness and management.
    Watson K, Watson BD, Pater KS.
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):365-79. PubMed ID: 17296541
    [Abstract] [Full Text] [Related]

  • 22. Risk of hospitalization for myocardial infarction among users of rofecoxib, celecoxib, and other NSAIDs: a population-based case-control study.
    Johnsen SP, Larsson H, Tarone RE, McLaughlin JK, Nørgård B, Friis S, Sørensen HT.
    Arch Intern Med; 2005 May 09; 165(9):978-84. PubMed ID: 15883235
    [Abstract] [Full Text] [Related]

  • 23. Adherence to evidence-based therapies after discharge for acute coronary syndromes: an ongoing prospective, observational study.
    Eagle KA, Kline-Rogers E, Goodman SG, Gurfinkel EP, Avezum A, Flather MD, Granger CB, Erickson S, White K, Steg PG.
    Am J Med; 2004 Jul 15; 117(2):73-81. PubMed ID: 15234641
    [Abstract] [Full Text] [Related]

  • 24. Optimal medical management of peripheral arterial disease.
    Rice TW, Lumsden AB.
    Vasc Endovascular Surg; 2006 Jul 15; 40(4):312-27. PubMed ID: 16959725
    [Abstract] [Full Text] [Related]

  • 25. Pharmacologic risk factor treatment of peripheral arterial disease is lacking and requires vascular surgeon participation.
    Bianchi C, Montalvo V, Ou HW, Bishop V, Abou-Zamzam AM.
    Ann Vasc Surg; 2007 Mar 15; 21(2):163-6. PubMed ID: 17349357
    [Abstract] [Full Text] [Related]

  • 26. Preventive drug use in patients with a history of nonfatal myocardial infarction during 12-year follow-up in The Netherlands: a retrospective analysis.
    van der Elst ME, Bouvy ML, de Blaey CJ, de Boer A.
    Clin Ther; 2005 Nov 15; 27(11):1806-14. PubMed ID: 16368451
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Acute treatment of myocardial infarction in Canada 1999-2002.
    Jackevicius CA, Alter D, Cox J, Daly P, Goodman S, Filate W, Newman A, Tu JV, Canadian Cardiovascular Outcomes Research Team.
    Can J Cardiol; 2005 Feb 15; 21(2):145-52. PubMed ID: 15729413
    [Abstract] [Full Text] [Related]

  • 29. Asymptomatic peripheral arterial disease: is pharmacological prevention of cardiovascular risk cost-effective?
    Sigvant B, Henriksson M, Lundin F, Wahlberg E.
    Eur J Cardiovasc Prev Rehabil; 2011 Apr 15; 18(2):254-61. PubMed ID: 21450673
    [Abstract] [Full Text] [Related]

  • 30. Lower extremity peripheral arterial disease in individuals with coronary artery disease: prognostic importance, care gaps, and impact of therapy.
    Makowsky MJ, McAlister FA, Galbraith PD, Southern DA, Ghali WA, Knudtson ML, Tsuyuki RT, Alberta Provincial Program for Outcome Assessment in Coronary Heart Disease (APPROACH) Investigators.
    Am Heart J; 2008 Feb 15; 155(2):348-55. PubMed ID: 18215607
    [Abstract] [Full Text] [Related]

  • 31. Contemporary cardiovascular risk and secondary preventive drug treatment patterns in peripheral artery disease patients undergoing revascularization.
    Sigvant B, Kragsterman B, Falkenberg M, Hasvold P, Johansson S, Thuresson M, Nordanstig J.
    J Vasc Surg; 2016 Oct 15; 64(4):1009-1017.e3. PubMed ID: 27209402
    [Abstract] [Full Text] [Related]

  • 32. Utilization of evidence-based therapy for the secondary prevention of acute coronary syndromes in Australian practice.
    Vermeer NS, Bajorek BV.
    J Clin Pharm Ther; 2008 Dec 15; 33(6):591-601. PubMed ID: 19138236
    [Abstract] [Full Text] [Related]

  • 33. Angiotensin II receptor blockers and myocardial infarction: an updated analysis of randomized clinical trials.
    Volpe M, Tocci G, Sciarretta S, Verdecchia P, Trimarco B, Mancia G.
    J Hypertens; 2009 May 15; 27(5):941-6. PubMed ID: 19381108
    [Abstract] [Full Text] [Related]

  • 34. Missed opportunities: despite improvement in use of cardioprotective medications among patients with lower-extremity peripheral artery disease, underuse remains.
    Subherwal S, Patel MR, Kober L, Peterson ED, Jones WS, Gislason GH, Berger J, Torp-Pedersen C, Fosbol EL.
    Circulation; 2012 Sep 11; 126(11):1345-54. PubMed ID: 22874581
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Evidence-based medication and revascularization: powerful tools in the management of patients with diabetes and coronary artery disease: a report from the Euro Heart Survey on diabetes and the heart.
    Anselmino M, Malmberg K, Ohrvik J, Rydén L, Euro Heart Survey Investigators.
    Eur J Cardiovasc Prev Rehabil; 2008 Apr 11; 15(2):216-23. PubMed ID: 18391651
    [Abstract] [Full Text] [Related]

  • 39. Outcome of patients with acute myocardial infarction admitted in hospitals with or without catheterization laboratory: results from the HELIOS registry.
    Pipilis A, Andrikopoulos G, Lekakis J, Kalantzi K, Kitsiou A, Toli K, Floros D, Gaita D, Karalis I, Dragomanovits S, Kalogeropoulos P, Synetos A, Koutsogiannis N, Stougiannos P, Antonakoudis C, Goudevenos J, HELIOS group.
    Eur J Cardiovasc Prev Rehabil; 2009 Feb 11; 16(1):85-90. PubMed ID: 19188809
    [Abstract] [Full Text] [Related]

  • 40. Drug secondary prevention in postmenopausal women with ischemic heart disease.
    Zdrenghea D, Pop D, Sitar-Tăut A, Cebanu M, Zdrenghea V.
    Rom J Intern Med; 2009 Feb 11; 47(1):41-5. PubMed ID: 19886068
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 33.